Comparing 22 vendors in Womens Health Diagnostics across 0 criteria.
ContendersMarket Leaders 
Emerging CompaniesInnovators 
Fujifilm
Carestream
Philips
Lantheus
Esaote
Guerbet
Aurora Health Care
Change Healthcare
Samsung
Bayer
Canon
Agfa-Gevaert
United Imaging
Sectra
Bracco
Mindray
ContextVision
GE
Hologic
Siemens Healthineers
iCAD
Merative
Access Research To
- Expand Total Addressable Market
- Formulate Go To Market Plans
- Build Competitive Right to Win
- Identify Top Customers to Grow
Error!!!
Oops! Something went wrong. Please try again later.
POWERED BY MARKETSANDMARKETS
Nov 23, 2024
The Women's Health Diagnostics Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Women's Health Diagnostics. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. MarketsandMarkets 360 Quadrants evaluated over 50 companies of which the Top 22 Women's Health Diagnostics Companies were categorized and recognized as the quadrant leaders.
Women's health refers to the medical specialty that focuses on management and care of clinical conditions that affects female physical or mental health. Few major clinical conditions related to women’s health include specific cancers (uterine cancer, cervical cancer, breast cancer, etc.), fibroids (breast fibroids, uterine fibroids, etc.), osteoporosis, reproductive/fertility-related conditions, dense breast tissues (DBT), menorrhagia, etc.
Specialized medical imaging technologies are utilized to diagnose various women’s health conditions including ultrasound, mammography, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), thermography, imaging modalities (used for guided biopsy), bone densitometers, etc.
The 360 Quadrant maps the Women's Health Diagnostics companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the Women's Health Diagnostics’ quadrant. While the top criteria for product footprint evaluation included Breadth of Offerings (2D Ultrasound, 3D Ultrasound, CT, FFDM, Biopsy - image guided or contrast, MRI, 3D Tomosynthesis, Molecular imaging, Thermography, Bone densitometry), Product Category Offered (Comprehensive Technology Solutions, Contrast Agents, Software, Systems, Services), Application Category Offered (Breast Cancer, Cervical Cancer, Ovarian Cancer, Uterine Cancer, Bone Metastasis, Fertility Monitoring, Menorrhagia, Fibroids & DBT), Dedicated portfolio/website for Women’s health, Product Launches & Approvals (AI-based Products Launch/Approval), Geography Specific Launch/Approval, (North America, Europe, Asia-Pacific, Middle East and Africa, Latin America), Value Addition And Company USP (Training and Education Services, Predictive Maintenance Service Offerings, Awareness Campaigns).
Key trends highlighted in 360 Quadrant’s study include:
- The global market for women's health diagnostics, in terms of revenue, is expected to reach USD 36.6 billion by 2025. The market's expansion is primarily fueled by increasing awareness of various health-related conditions, the escalating incidence of chronic and lifestyle diseases, and the prevalent occurrence of infectious diseases like HIV and hepatitis among women worldwide. Furthermore, the rising adoption of point-of-care (POC) diagnostic testing and the proliferation of diagnostic and imaging centers are anticipated to bolster market growth. However, challenges such as the high cost of diagnostic devices, tests, and procedures, a shortage of skilled laboratory technicians, and inadequate reimbursements for diagnostic tests are expected to temper the market's growth to some extent.
- In 2023, North America led the women's health diagnostics industry in market share, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. The significant market share in this region stems from the rising incidence of cancer among women, the concerted efforts of women's health diagnostic product manufacturers to extend their footprint here, and the growing need for fertility testing monitors. Furthermore, the increasing adoption of point-of-care diagnostics and preventative screening and testing practices is anticipated to fuel the expansion of this regional sector in the foreseeable future.
- Women's Health Diagnostics Companies are adopting various strategies such as geographic expansions, new product launches, partnerships, and acquisitions to accelerate their position in the market. The key players have been trying to strengthen their product & service portfolios and cater to the untapped markets. For instance, in January 2024, Hologic, unveiled that its latest innovation, the Genius Digital Diagnostics System featuring the Genius Cervical AI algorithm, has been granted clearance by the U.S. Food and Drug Administration (FDA). This achievement marks it as the pioneering digital cytology system to receive FDA clearance, integrating state-of-the-art deep-learning-based artificial intelligence (AI) with advanced volumetric imaging technology. Its primary purpose is to aid in the detection of pre-cancerous lesions and cervical cancer cells. Similarly, in October 2023, Philips unveiled its latest advancements in OB/GYN ultrasound at ISUOG 2023, aimed at enhancing early detection and diagnostic confidence.
- The high prevalence of infectious diseases in women creates significant opportunities for Women's Health diagnostics companies. Women are disproportionately affected by various infections, necessitating accurate and timely diagnostics for early detection and treatment. Advanced technologies in molecular diagnostics and point-of-care testing are crucial in identifying infectious agents promptly. As the demand for innovative diagnostic solutions rises, Women's Health diagnostics companies stand to benefit from the expanding market and increased focus on women's health issues.
- The improvement of healthcare infrastructure in emerging healthcare markets serves as a significant driver for the women's health diagnostics market. As these regions undergo infrastructural enhancements, including the establishment of medical facilities, expansion of healthcare coverage, and increased accessibility to diagnostic services, there emerges a greater awareness and demand for women's health diagnostics. Improved infrastructure facilitates better access to healthcare services, leading to more women seeking preventative screenings and diagnostic tests. This surge in demand creates a favorable environment for women's health diagnostics companies to expand their market presence and introduce innovative diagnostic solutions tailored to the specific needs of women. Additionally, as healthcare infrastructure improves, regulatory frameworks may evolve to support the adoption of advanced diagnostic technologies, providing further opportunities for companies in this sector to thrive and innovate.
The Full List
The Full List
| Company | Headquarters | Year Founded | Holding Type |
|---|---|---|---|
| Agfa-Gevaert | Mortsel, Belgium | 1867 | Public |
| Aurora Health Care | Milwaukee, USA | 1984 | Private |
| Bayer | Leverkusen, Germany | 1863 | Public |
| Bracco | Milan, Italy | 1927 | Private |
| Canon | Tokyo, Japan | 1937 | Public |
| Carestream | Rochester, USA | 2007 | Private |
| Change Healthcare | Nashville, USA | 2007 | Private |
| ContextVision | Stockholm, Sweden | 1983 | Public |
| Esaote | Genova, Italy | 1982 | Private |
| Fujifilm | Tokyo, Japan | 1934 | Private |
| GE | Chicago, USA | 1990 | Public |
| Guerbet | Villepinte, France | 1926 | Public |
| Hologic | Marlborough, USA | 1985 | Public |
| Lantheus | Bedford, USA | 1956 | Public |
| Merative | Ann Arbor, USA | 2022 | Private |
| Mindray | Shenzhen, China | 1991 | Public |
| Philips | Amsterdam, Netherlands | 1891 | Public |
| Samsung | Seoul, South Korea | 1969 | Public |
| Sectra | Linköping, Sweden | 1978 | Public |
| Siemens Healthineers | Erlangen, Germany | 1847 | Public |
| United Imaging | Shanghai, China | 2011 | Private |
| iCAD | Nashua, USA | 1984 | Public |
Frequently Asked Questions (FAQs)
A women's health test refers to any diagnostic procedure or screening method specifically designed to assess and monitor various aspects of a woman's health, particularly related to her reproductive system, hormonal balance, and overall well-being. These tests may include screenings for conditions such as breast cancer, cervical cancer, ovarian cancer, sexually transmitted infections, hormonal imbalances, and pregnancy-related issues. Women's health tests can range from simple blood tests and imaging studies to more specialized procedures like Pap smears, mammograms, pelvic exams, and genetic screenings. The goal of these tests is to detect potential health problems early, facilitate timely interventions, and promote optimal health outcomes for women at different stages of life.
Some of the top women's health diagnostics companies include: Agfa-Gevaert, Aurora Health Care, Bayer, Bracco, Canon, Carestream, Change Healthcare, ContextVision, Esaote, Fujifilm, GE, Guerbet, Hologic, Lantheus, Merative, Mindray, Philips, Samsung, Sectra, Siemens Healthineers, United Imaging, and iCAD.
Medical imaging can diagnose a wide range of conditions, including fractures, tumors, cardiovascular diseases, neurological disorders, and gastrointestinal issues, among others.
General tests for females typically include screenings and diagnostic procedures aimed at assessing various aspects of their health, including reproductive health, hormonal balance, and overall well-being. Some common general tests for females include:
Pap Smear (Pap Test): A screening test to detect abnormal cells in the cervix, which may indicate cervical cancer or precancerous conditions.
Mammogram: A screening test for breast cancer that uses X-rays to detect abnormalities, such as tumors or cysts, in breast tissue.
Pelvic Exam: A physical examination of the pelvic organs, including the uterus, ovaries, and cervix, to check for abnormalities, such as cysts, fibroids, or signs of infection.
Blood Pressure Measurement: A routine test to monitor blood pressure levels, which can indicate risk factors for cardiovascular disease and other health conditions.
Cholesterol Test: A blood test to measure cholesterol levels, including LDL (bad) cholesterol, HDL (good) cholesterol, and triglycerides, to assess cardiovascular health.
Blood Glucose Test: A test to measure blood sugar levels, which helps diagnose diabetes and monitor glucose control in individuals with diabetes.
Bone Density Test (DEXA Scan): A screening test to measure bone mineral density and assess the risk of osteoporosis and fractures, particularly in postmenopausal women.
Thyroid Function Test: A blood test to measure levels of thyroid hormones (TSH, T3, T4) to assess thyroid function and diagnose conditions such as hypothyroidism or hyperthyroidism.
Hormone Level Testing: Blood tests to measure levels of hormones such as estrogen, progesterone, testosterone, and thyroid hormones to assess hormonal balance and diagnose conditions like PCOS or thyroid disorders.
STI Screening: Tests for sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, and HIV, which are important for sexual health and preventive care.
These tests may be recommended as part of routine preventive care or based on individual risk factors, age, and medical history. It's essential for women to discuss their health concerns and screening needs with their healthcare providers to determine the most appropriate tests for their specific circumstances.
Medical imaging software solutions encompass a variety of applications designed to process, analyze, and manage medical images from different modalities. These include Picture Archiving and Communication Systems (PACS) for image storage and retrieval, Radiology Information Systems (RIS) for workflow management, DICOM viewers for image interpretation, and 3D visualization software for detailed anatomical representation. Image analysis software employs algorithms for quantitative data extraction, while advanced visualization tools enhance image interpretation with features like multi-planar reconstruction and virtual reality visualization. Integration solutions ensure seamless interoperability between imaging systems and other healthcare IT platforms, while remote viewing solutions enable access to images from any location. AI applications automate image analysis and assist radiologists in interpretation, while workflow optimization tools streamline radiology processes. Together, these software solutions support efficient image management, accurate diagnosis, and improved patient care in medical imaging.
The four main types of diagnostic imaging techniques are X-ray imaging, which uses electromagnetic radiation to visualize bones and tissues; computed tomography (CT) scans, which produce cross-sectional images of the body using multiple X-ray images; magnetic resonance imaging (MRI), which generates detailed images of internal structures using strong magnetic fields and radio waves; and ultrasound imaging, which creates real-time images of organs and tissues using high-frequency sound waves. Each technique has its strengths and is used to diagnose various medical conditions, ranging from fractures and tumors to cardiovascular and neurological disorders.
Yes, AI is increasingly used in medical imaging to assist healthcare professionals in interpreting images, improving diagnostic accuracy, and streamlining workflow. AI algorithms can analyze medical images such as X-rays, CT scans, MRI scans, and ultrasounds to detect abnormalities, segment organs and tissues, and classify pathology. AI applications in medical imaging include image reconstruction, image enhancement, automated lesion detection, quantification of disease severity, and prediction of patient outcomes. By harnessing the power of machine learning and deep learning algorithms, AI has the potential to revolutionize medical imaging by providing faster, more accurate diagnoses, reducing variability among radiologists, and ultimately improving patient care.
Yes, medical imaging is generally safe when performed by trained professionals and used appropriately. While certain imaging modalities, such as X-rays and CT scans, involve ionizing radiation and carry a small risk of radiation exposure, doses are typically low and considered safe. Healthcare providers follow guidelines to minimize radiation exposure and ensure the benefits outweigh the risks. Contrast agents used in some imaging studies may cause rare allergic reactions, and certain individuals with metal implants or medical devices may not be suitable candidates for MRI. However, ultrasound imaging, which uses sound waves and does not involve radiation, is considered safe and non-invasive for most patients. Overall, medical imaging procedures prioritize patient safety, and any potential risks are carefully managed and monitored by healthcare professionals.
Medical imaging results are generally highly accurate, but interpretation may vary based on factors such as the experience of the interpreting physician and the quality of the equipment.
Yes, emerging technologies like 3D imaging, molecular imaging, and artificial intelligence-driven image analysis are expanding the capabilities of medical imaging, offering alternatives or complementary approaches to traditional methods.
Research Methodology
Related Markets
If your company is recognised in this Quadrant, Leverage this ranking using our Marketing Kit.
